FTC Continues To Target 'Junk' Drug Patents

By Adam Lidgett · April 30, 2024, 7:15 PM EDT

Federal trade officials told a series of pharmaceutical companies — including the makers of the controversial diabetes and weight loss drug Ozempic — that they may have listed faulty patents in...

To view the full article, register now.